Tarsons Products Limited (TARSONS) - Net Assets
Based on the latest financial reports, Tarsons Products Limited (TARSONS) has net assets worth Rs6.35 Billion INR (≈ $68.63 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs11.86 Billion ≈ $128.24 Million USD) and total liabilities (Rs5.51 Billion ≈ $59.61 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check strategic asset allocation of Tarsons Products Limited to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs6.35 Billion |
| % of Total Assets | 53.51% |
| Annual Growth Rate | 24.71% |
| 5-Year Change | 29.55% |
| 10-Year Change | N/A |
| Growth Volatility | 32.79 |
Tarsons Products Limited - Net Assets Trend (2019–2026)
This chart illustrates how Tarsons Products Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Tarsons Products Limited (TARSONS) market capitalisation.
Annual Net Assets for Tarsons Products Limited (2019–2026)
The table below shows the annual net assets of Tarsons Products Limited from 2019 to 2026. Also explore Tarsons Products Limited annual equity growth to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | Rs6.35 Billion ≈ $68.63 Million |
+0.69% |
| 2025-03-31 | Rs6.30 Billion ≈ $68.15 Million |
+2.83% |
| 2024-03-31 | Rs6.13 Billion ≈ $66.28 Million |
+7.65% |
| 2023-03-31 | Rs5.69 Billion ≈ $61.57 Million |
+16.22% |
| 2022-03-31 | Rs4.90 Billion ≈ $52.97 Million |
+100.47% |
| 2021-03-31 | Rs2.44 Billion ≈ $26.42 Million |
+23.67% |
| 2020-03-31 | Rs1.98 Billion ≈ $21.37 Million |
+46.05% |
| 2019-03-31 | Rs1.35 Billion ≈ $14.63 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Tarsons Products Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 268.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs4.89 Billion | 76.97% |
| Common Stock | Rs106.41 Million | 1.68% |
| Other Components | Rs1.36 Billion | 21.35% |
| Total Equity | Rs6.35 Billion | 100.00% |
Tarsons Products Limited Competitors by Market Cap
The table below lists competitors of Tarsons Products Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Indeks Bilgisayar Sistemleri Muhendislik Sanayi ve Ticaret AS
IS:INDES
|
$176.21 Million |
|
BAPCOR LTD.
F:0BS
|
$176.26 Million |
|
Crown Reserve Acquisition Corp. I Class A Ordinary Shares
NASDAQ:CRAC
|
$176.29 Million |
|
Melar Acquisition Corp. I Class A Ordinary Shares
NASDAQ:MACI
|
$176.32 Million |
|
RADCOM Ltd
F:RAM
|
$176.12 Million |
|
Canton Strategic Holdings, Inc.
NASDAQ:CNTN
|
$176.10 Million |
|
Caisse Regionale de Credit Agricole Mutuel du Languedoc
PA:CRLA
|
$176.01 Million |
|
Jaeren Sparebank
OL:JAREN
|
$175.96 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Tarsons Products Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 6,302,110,000 to 6,346,890,000, a change of 44,780,000 (0.7%).
- Net income of 143,220,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 150,000.
- Other factors decreased equity by 98,590,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs143.22 Million | +2.26% |
| Other Comprehensive Income | Rs150.00K | +0.0% |
| Other Changes | Rs-98.59 Million | -1.55% |
| Total Change | Rs- | 0.71% |
Book Value vs Market Value Analysis
This analysis compares Tarsons Products Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.57x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 12.18x to 2.57x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-03-31 | Rs25.13 | Rs306.10 | x |
| 2020-03-31 | Rs35.86 | Rs306.10 | x |
| 2021-03-31 | Rs47.65 | Rs306.10 | x |
| 2022-03-31 | Rs94.67 | Rs306.10 | x |
| 2023-03-31 | Rs106.99 | Rs306.10 | x |
| 2024-03-31 | Rs115.18 | Rs306.10 | x |
| 2025-03-31 | Rs118.64 | Rs306.10 | x |
| 2026-03-31 | Rs119.21 | Rs306.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Tarsons Products Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 2.26%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.39%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 1.87x
- Recent ROE (2.26%) is below the historical average (15.77%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 28.80% | 21.93% | 0.84x | 1.57x | Rs254.31 Million |
| 2020 | 20.51% | 23.16% | 0.70x | 1.26x | Rs207.74 Million |
| 2021 | 28.19% | 30.22% | 0.77x | 1.21x | Rs444.36 Million |
| 2022 | 20.55% | 33.47% | 0.55x | 1.11x | Rs516.81 Million |
| 2023 | 14.18% | 28.50% | 0.39x | 1.27x | Rs237.84 Million |
| 2024 | 6.96% | 14.39% | 0.30x | 1.59x | Rs-186.46 Million |
| 2025 | 4.72% | 7.59% | 0.36x | 1.71x | Rs-332.51 Million |
| 2026 | 2.26% | 3.39% | 0.36x | 1.87x | Rs-491.47 Million |
Industry Comparison
This section compares Tarsons Products Limited's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $278,573,000
- Average return on equity (ROE) among peers: 25.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Tarsons Products Limited (TARSONS) | Rs6.35 Billion | 28.80% | 0.87x | $176.13 Million |
| Poly Medicure Limited (POLYMED) | $278.57 Million | 25.76% | 1.06x | $1.89 Billion |
About Tarsons Products Limited
Tarsons Products Limited manufactures and trades in scientific plastic labware products in India and internationally. The company offers assay plates, biohazard and safetyware, bioprocessing solutions, bottles and carboys, boxes and racks, cell culture ware, centrifuge ware, clamps and stands, clinical and microbiology products, cryoware, desiccators, tubings and connectors, filtration products, … Read more